Campbell & Co. Investment Adviser »

Revance Therapeutics shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.2M 101k 11.47
2023-06-30 $401k 16k 25.31
2022-12-31 $524k 28k 18.46
2021-06-30 $373k 13k 29.60
2019-03-31 $170k 11k 15.78

More positions owned by Campbell & Co. Investment Adviser

General Mills Common Stock (GIS)
HP Common Stock (HPQ)
Beyond Common Stock (BBY)
Pioneer Natural Resources Common Stock (PXD)
Cencora Common Stock (COR)
Fiserv Common Stock (FI)
Travelers Cos Inc/The Common Stock (TRV)
Hershey Co/The Common Stock (HSY)
Jack in the Box Common Stock (JACK)
Insulet Corp Common Stock (PODD)
Boise Cascade Common Stock (BCC)
Shake Shack Common Stock (SHAK)
Tapestry Common Stock (TPR)
Interpublic Group of Cos Inc/T Common Stock (IPG)
Beacon Roofing Supply Common Stock (BECN)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Revance Therapeutics

Palo Alto Investors
Vanguard Group
Franklin Resources
Jpmorgan Chase & Co
Jennison Associates
Bamco
Walleye Trading Advisors
Goldman Sachs Group
Rice Hall James & Associates
Charles Schwab Investment Management
Citadel Advisors
Wellington Management Company
D. E. Shaw & Co
HighTower Advisors
Balyasny Asset Management

View all funds holding Revance Therapeutics